Presentation is loading. Please wait.

Presentation is loading. Please wait.

Bendamustine Versus Chlorambucil for the First-Line Treatment of Chronic Lymphocytic Leukemia in England and Wales: A Cost-Utility Analysis Beth Woods,

Published byHomer Turner Modified over 8 years ago

Similar presentations

Presentation on theme: "Bendamustine Versus Chlorambucil for the First-Line Treatment of Chronic Lymphocytic Leukemia in England and Wales: A Cost-Utility Analysis Beth Woods,"— Presentation transcript:

1 Bendamustine Versus Chlorambucil for the First-Line Treatment of Chronic Lymphocytic Leukemia in England and Wales: A Cost-Utility Analysis Beth Woods, MSc, Neil Hawkins, PhD, William Dunlop, MEc, Alison O'Toole, MB BS, FRCA, PhD, MFPM, Steve Bramham-Jones, DipAM Value in Health Volume 15, Issue 5, Pages 759-770 (July 2012) DOI: 10.1016/j.jval.2012.03.1389 Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions Terms and Conditions

2 Fig. 1 Value in Health 2012 15, 759-770DOI: (10.1016/j.jval.2012.03.1389) Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions Terms and Conditions

3 Fig. 2 Value in Health 2012 15, 759-770DOI: (10.1016/j.jval.2012.03.1389) Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions Terms and Conditions

4 Fig. 3 Value in Health 2012 15, 759-770DOI: (10.1016/j.jval.2012.03.1389) Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions Terms and Conditions

5 Fig. 4 Value in Health 2012 15, 759-770DOI: (10.1016/j.jval.2012.03.1389) Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions Terms and Conditions

6 Fig. 5 Value in Health 2012 15, 759-770DOI: (10.1016/j.jval.2012.03.1389) Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions Terms and Conditions

7 Fig 6 Value in Health 2012 15, 759-770DOI: (10.1016/j.jval.2012.03.1389) Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions Terms and Conditions

Download ppt "Bendamustine Versus Chlorambucil for the First-Line Treatment of Chronic Lymphocytic Leukemia in England and Wales: A Cost-Utility Analysis Beth Woods,"

Similar presentations

Consolidated Health Economic Evaluation Reporting Standards (CHEERS)— Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication.

Consolidated Health Economic Evaluation Reporting Standards (CHEERS)— Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication.
A Meta-Analysis of Osteoporotic Fracture Risk with Medication Nonadherence Susan Ross, MD, FRCPC, Ebony Samuels, PhD, Kerry Gairy, MSc, Sheikh Iqbal, MD,

A Meta-Analysis of Osteoporotic Fracture Risk with Medication Nonadherence Susan Ross, MD, FRCPC, Ebony Samuels, PhD, Kerry Gairy, MSc, Sheikh Iqbal, MD,
Program-Specific Cost-Effectiveness Analysis: Breast Cancer Screening Policies for a Safety-Net Program Joy Melnikow, MD, MPH, Daniel J. Tancredi, PhD,

Program-Specific Cost-Effectiveness Analysis: Breast Cancer Screening Policies for a Safety-Net Program Joy Melnikow, MD, MPH, Daniel J. Tancredi, PhD,
Cost-Effectiveness of Incobotulinumtoxin-A with Flexible Treatment Intervals Compared to Onabotulinumtoxin-A in the Management of Blepharospasm and Cervical.

Cost-Effectiveness of Incobotulinumtoxin-A with Flexible Treatment Intervals Compared to Onabotulinumtoxin-A in the Management of Blepharospasm and Cervical.
Cost-Effectiveness of Sensor-Augmented Pump Therapy in Adults with Type 1 Diabetes in the United States Shital Kamble, PhD, Kevin A. Schulman, MD, Shelby.

Cost-Effectiveness of Sensor-Augmented Pump Therapy in Adults with Type 1 Diabetes in the United States Shital Kamble, PhD, Kevin A. Schulman, MD, Shelby.
Cost-Effectiveness of Partially Hydrolyzed Whey Protein Formula in the Primary Prevention of Atopic Dermatitis in At-Risk Urban Filipino Infants Abhijeet.

Cost-Effectiveness of Partially Hydrolyzed Whey Protein Formula in the Primary Prevention of Atopic Dermatitis in At-Risk Urban Filipino Infants Abhijeet.
Volume 14, Issue 8, Pages (December 2011)

Volume 14, Issue 8, Pages (December 2011)
Economic Burden of Illness among Persons with Hemophilia B from HUGS Vb: Examining the Association of Severity and Treatment Regimens with Costs and Annual.

Economic Burden of Illness among Persons with Hemophilia B from HUGS Vb: Examining the Association of Severity and Treatment Regimens with Costs and Annual.
Volume 18, Issue 4, Pages (June 2015)

Volume 18, Issue 4, Pages (June 2015)
Volume 18, Issue 5, Pages (July 2015)

Volume 18, Issue 5, Pages (July 2015)
Mapping the COPD Assessment Test onto EQ-5D

Mapping the COPD Assessment Test onto EQ-5D
Performance Assessment of the Juaboso District Office of the National Health Insurance Authority  Paul Effah, MBA, Kingsley Opoku Appiah, PhD, FCCA, Patience.

Performance Assessment of the Juaboso District Office of the National Health Insurance Authority  Paul Effah, MBA, Kingsley Opoku Appiah, PhD, FCCA, Patience.
Mapping from the Health Assessment Questionnaire to the EQ-5D: The Impact of Different Algorithms on Cost-Effectiveness Results  Becky Pennington, MSc,

Mapping from the Health Assessment Questionnaire to the EQ-5D: The Impact of Different Algorithms on Cost-Effectiveness Results  Becky Pennington, MSc,
Volume 17, Issue 2, Pages (March 2014)

Volume 17, Issue 2, Pages (March 2014)
Volume 15, Issue 1, Pages S20-S28 (January 2012)

Volume 15, Issue 1, Pages S20-S28 (January 2012)
Volume 14, Issue 4, Pages (June 2011)

Volume 14, Issue 4, Pages (June 2011)
Volume 17, Issue 8, Pages (December 2014)

Volume 17, Issue 8, Pages (December 2014)
Cost-effectiveness Analysis of Viscosupplementation versus Conventional Supportive Therapy for Knee Osteoarthritis in Colombia  Juan-Carlos Castro, MD,

Cost-effectiveness Analysis of Viscosupplementation versus Conventional Supportive Therapy for Knee Osteoarthritis in Colombia  Juan-Carlos Castro, MD,
Volume 17, Issue 8, Pages (December 2014)

Volume 17, Issue 8, Pages (December 2014)
Volume 14, Issue 4, Pages (June 2011)

Volume 14, Issue 4, Pages (June 2011)

Similar presentations

Ads by Google